Eagle Meds Services
TAGRISSO (osimertinib)
Available to sourceHuman Prescription DrugOncology & Specialty

TAGRISSO (osimertinib)

40 mg/1 · Film-Coated Tablet
By AstraZeneca Pharmaceuticals LP
NDC
0310-1349
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor , Kinase Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 30 TABLET, FILM COATED in 1 BOTTLE (0310-1349-30)NDC 0310-1349-30Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
TAGRISSO (osimertinib)
NDC 0310-1349
(980) 480-3410 requests@eaglemedsservices.com

Related in Oncology & Specialty

See all →
Verzenio (abemaciclib)

Verzenio (abemaciclib)

50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

150 mg/1 · Tablet
Eli Lilly and Company
Available to source